PharmaShots | Incisive News in 3 Shots

Subscribe Now

every six weeks

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Additional Recommended Dose of 400 mg Every Six Weeks for All Approved Indications

Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Additional Recommended Dose of 400 mg Every Six Weeks for All...

April 29, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us